rs1554660803
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_004817.4(TJP2):c.813_814delCG(p.Ala273ProfsTer27) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004817.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- cholestasis, progressive familial intrahepatic, 4Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
- familial hypercholanemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypercholanemia, familial 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TJP2 | ENST00000377245.9 | c.813_814delCG | p.Ala273ProfsTer27 | frameshift_variant | Exon 5 of 23 | 1 | NM_004817.4 | ENSP00000366453.4 | ||
| ENSG00000285130 | ENST00000642889.1 | c.1200_1201delCG | p.Ala402ProfsTer27 | frameshift_variant | Exon 7 of 25 | ENSP00000493780.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cholestasis, progressive familial intrahepatic, 4 Pathogenic:1
This frameshift variant is categorized as deleterious according to ACMG guidelines (PMID:18414213). It was found once in this study homozygous in a 2-year-old male with hepatocellular carcinoma, severe cholestatic liver disease requiring transplant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at